Full Text View
Tabular View
No Study Results Posted
Related Studies
COMBISTRAT: AmBisome® in Combination With Caspofungin for the Treatment of Invasive Aspergillosis
This study has been completed.
Study NCT00334412   Information provided by Gilead Sciences

First Received on June 5, 2006.   Last Updated on October 5, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Invasive Aspergillosis
Additional conditions recognized in this trial
Aspergillosis
More general conditions related to this trial
Mycoses
Interventions listed in this trial
Ambisome
caspofungin
Additional drug interventions recognized in this trial
Amphotericin B
Liposomal amphotericin B
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antifungal Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Gilead Sciences


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services